http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-9902135-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880cc8535f892eca8121f608c316808c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
filingDate 1997-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9b130b2fb0f0af69eccaf55d22a419e
publicationDate 1999-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-9902135-A2
titleOfInvention Use of (+) - alpha- (2,3-Dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidinium methanol for the manufacture of a medicament for the treatment of depressive and bipolar disorders
abstract The present invention relates to the use of (+) -? - (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidine methane, or a pharmaceutically acceptable acid addition salt thereof, optionally with a pharmaceutically acceptable bath. mixed to form a medicament for the treatment of depressive and bipolar disorder. ŕ
priorityDate 1996-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455728551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297

Total number of triples: 21.